Retaglutide is a cutting-edge GLP-1 receptor agonist currently under investigation for the management of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally https://ammarnldr384048.webbuzzfeed.com/39377098/trelaglutide-exploring-a-new-option-for-chronic-diseases